<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-116027" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Viral Hemorrhagic Fevers</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mangat</surname>
            <given-names>Rupinder</given-names>
          </name>
          <aff>University of Rochester Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Louie</surname>
            <given-names>Ted</given-names>
          </name>
          <aff>University of Rochester Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Rupinder Mangat declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ted Louie declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>28</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-116027.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Viral hemorrhagic fevers (VHFs) represent a group of severe systemic febrile illnesses caused by four families of viruses - Arenaviridae, Bunyaviridae, Filoviridae, and Flaviviridae. These enveloped viruses are characterized by a myriad of symptoms that range from coagulopathies, hemodynamic instability, altered mental status, and, if severe enough, death. This activity outlines the evaluation and management of viral hemorrhagic fevers and highlights the role of the interprofessional team in the care of patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of viral hemorrhagic fevers.</p></list-item><list-item><p>Review the appropriate evaluation of patients with viral hemorrhagic fevers.</p></list-item><list-item><p>Describe the management of viral hemorrhagic fevers.</p></list-item><list-item><p>Summarize interprofessional team strategies for improving care coordination and communication to improve outcomes in patients with viral hemorrhagic fevers.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=116027&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=116027">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-116027.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Viral&#x000a0;hemorrhagic&#x000a0;fevers (VHFs) represent a group of severe systemic febrile illnesses&#x000a0;caused by four families of viruses -&#x000a0;<italic toggle="yes">Arenaviridae</italic>,&#x000a0;<italic toggle="yes">Bunyaviridae</italic>,&#x000a0;<italic toggle="yes">Filoviridae</italic>, and&#x000a0;<italic toggle="yes">Flaviviridae.</italic><xref ref-type="bibr" rid="article-116027.r1">[1]</xref>&#x000a0;These enveloped viruses are characterized by a myriad of symptoms that range from coagulopathies, hemodynamic instability, altered mental status, and, if severe enough, death. The degree of clinical illness can vary widely with some viruses causing mild illness, while others can be life-threatening.</p>
        <p>Most of the viruses implicated in these diseases require vectors for transmission to humans, with the majority being arthropod-borne&#x000a0;or rodent-borne infections.&#x000a0;Given their zoonotic nature, these diseases are generally confined to the endemic areas where their hosts live. However, given&#x000a0;increased human migration and&#x000a0;further&#x000a0;globalization, these diseases are no longer limited to their geographic origins.<xref ref-type="bibr" rid="article-116027.r2">[2]</xref>&#x000a0;This article will provide a general overview of viral hemorrhagic fevers and focus on those diseases which have the highest overall mortality rates.</p>
      </sec>
      <sec id="article-116027.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Viruses implicated in viral hemorrhagic fevers and the diseases they cause are grouped by the family of viruses:</p>
        <p><italic toggle="yes">Arenaviridae</italic>&#x000a0;family:</p>
        <list list-type="bullet">
          <list-item>
            <p>Chapare virus (CHPV) - Chapare hemorrhagic fever</p>
          </list-item>
          <list-item>
            <p>Guanarito virus (GTOV) - Venezuelan hemorrhagic fever</p>
          </list-item>
          <list-item>
            <p>Junin virus (JUNV) - Argentine&#x000a0;hemorrhagic fever</p>
          </list-item>
          <list-item>
            <p>Lassa virus (LASV)&#x000a0;- Lassa fever</p>
          </list-item>
          <list-item>
            <p>Lujo virus (LUJV) - Lujo&#x000a0;hemorrhagic fever</p>
          </list-item>
          <list-item>
            <p>Lymphocytic choriomeningitis virus (LCMV)&#x000a0;- Lymphocytic choriomeningitis</p>
          </list-item>
          <list-item>
            <p>Machupo virus (MACV)&#x000a0;- Bolivian&#x000a0;hemorrhagic fever</p>
          </list-item>
          <list-item>
            <p>Sabia virus (SABV)&#x000a0;- Brazilian&#x000a0;hemorrhagic fever</p>
          </list-item>
        </list>
        <p><italic toggle="yes">Bunyaviridae</italic>&#x000a0;family:</p>
        <list list-type="bullet">
          <list-item>
            <p>Crimean-Congo hemorrhagic virus (CCHFV) - Crimean-Congo&#x000a0;hemorrhagic fever</p>
          </list-item>
          <list-item>
            <p>Dobrava-Belgrade virus (DOBV) - Hemorrhagic fever with renal syndrome</p>
          </list-item>
          <list-item>
            <p>Hantaan virus (HTNV)&#x000a0;- Hemorrhagic fever with renal syndrome</p>
          </list-item>
          <list-item>
            <p>Puumalavirus (PUUV)&#x000a0;- Hemorrhagic fever with renal syndrome</p>
          </list-item>
          <list-item>
            <p>Rift Valley fever virus (RVFV) - Rift Valley fever</p>
          </list-item>
          <list-item>
            <p>Saaremaa virus (SAAV)&#x000a0;- Hemorrhagic fever with renal syndrome</p>
          </list-item>
          <list-item>
            <p>Seoul virus (SEOV)&#x000a0;- Hemorrhagic fever with renal syndrome</p>
          </list-item>
          <list-item>
            <p>Sin Nombre virus (SNV)- Hantavirus pulmonary syndrome</p>
          </list-item>
          <list-item>
            <p>Severe fever and thrombocytopenia syndrome virus (SFTSV) -&#x000a0;Severe fever and thrombocytopenia syndrome</p>
          </list-item>
          <list-item>
            <p>Tula virus (TULV) -&#x000a0;Hemorrhagic fever with renal syndrome</p>
          </list-item>
        </list>
        <p><italic toggle="yes">Filoviridae</italic>&#x000a0;family:</p>
        <list list-type="bullet">
          <list-item>
            <p>Bundibugyo ebolavirus (BDBV) - Ebola virus disease</p>
          </list-item>
          <list-item>
            <p>Marburg marburgvirus (MARV) - Marburg&#x000a0;hemorrhagic&#x000a0;fever</p>
          </list-item>
          <list-item>
            <p>Sudan ebolavirus (SUDV) -&#x000a0;Ebola virus disease</p>
          </list-item>
          <list-item>
            <p>Ta&#x000ef; Forest ebolavirus (TAFV) -&#x000a0;Ebola virus disease</p>
          </list-item>
          <list-item>
            <p>Zaire ebolavirus (EBOV) -&#x000a0;Ebola virus disease</p>
          </list-item>
        </list>
        <p><italic toggle="yes">Flaviviridae</italic>&#x000a0;family:</p>
        <list list-type="bullet">
          <list-item>
            <p>Dengue virus (DENV-1-4) - Dengue fever</p>
          </list-item>
          <list-item>
            <p>Kyasanur forest disease virus (KFDV) - Kyasanur forest disease</p>
          </list-item>
          <list-item>
            <p>Omsk hemorrhagic fever virus (OHFV) - Omsk hemorrhagic fever</p>
          </list-item>
          <list-item>
            <p>Yellow fever virus (YFV) - Yellow fever</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-116027.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Viruses belonging to the family <italic toggle="yes">Arenaviridae</italic> are associated with rodent-borne diseases. These viruses are divided into two groups, New World and Old World. Each virus is affiliated with rodents that can be found across Africa, America, Asia, and Europe. Infection occurs via contact with rodent&#x000a0;urine or droppings and can also occur via aerosol transmission when rodent excrement is stirred up,&#x000a0;causing&#x000a0;viral particles to get into the air. Some viruses can also cause human-to-human and nosocomial infections. Lassa virus, an arenavirus, has caused outbreaks in West Africa with case fatality rates as high as 50%.<xref ref-type="bibr" rid="article-116027.r3">[3]</xref>&#x000a0;This virus spreads efficiently, mostly through direct contact with multimammate rats, but infection can also occur when rodents are captured for consumption.<xref ref-type="bibr" rid="article-116027.r3">[3]</xref></p>
        <p>Bunyaviruses are transmitted via arthropods and rodents and can cause mild to severe illness. These viruses can cause Crimean-Congo hemorrhagic fever, hantavirus infections, and Rift Valley fever. Crimean-Congo hemorrhagic fever is an important disease entity to be aware of as it is the most widespread tick-borne illness in humans.<xref ref-type="bibr" rid="article-116027.r4">[4]</xref>&#x000a0;This disease is caused by a Nairovirus that can be transmitted by Ixodid ticks and is endemic in Africa and Asia. Transmission also occurs via exposure to blood or other bodily fluids and can lead to a severe infection with high mortality risk.<xref ref-type="bibr" rid="article-116027.r5">[5]</xref>&#x000a0;</p>
        <p>Filoviruses are the culprits implicated in Ebola virus disease and Marburg hemorrhagic fever and have been detected in bats in Africa. Once humans are infected, there is a risk of person-to-person spread, especially in those caring for infected patients. There have been several Ebola outbreaks in the Democratic Republic of the Congo, with case fatality rates as high as 80%&#x000a0;to 90%.<xref ref-type="bibr" rid="article-116027.r6">[6]</xref>&#x000a0;Fatality rates for Marburg hemorrhagic fever are also as high as 82% in low-income countries.<xref ref-type="bibr" rid="article-116027.r7">[7]</xref></p>
        <p>Flaviviruses can cause a range of different diseases and can be transmitted via arthropods. Dengue virus, a flavivirus, is transmitted by&#x000a0;<italic toggle="yes">Aedes aegypti</italic>&#x000a0;or&#x000a0;<italic toggle="yes">Aedes albopictus</italic>&#x000a0;mosquitoes. Clinically, this virus can cause disease, which can be classified into&#x000a0;three categories: dengue without warning signs, dengue&#x000a0;with warning signs, and&#x000a0;severe dengue. This disease is endemic in over 100 countries and can be found in Africa, the Americas, Asia, Australia, Europe, and the Pacific Islands.<xref ref-type="bibr" rid="article-116027.r8">[8]</xref>&#x000a0;Dengue fever has a mortality rate of 0.8%&#x000a0;to 2.5% with more severe morbidity and mortality associated with dengue hemorrhagic fever and dengue shock syndrome.<xref ref-type="bibr" rid="article-116027.r8">[8]</xref></p>
      </sec>
      <sec id="article-116027.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Pathogens implicated in viral hemorrhagic fevers are able to replicate within macrophages and dendritic cells, allowing for rapid dissemination within the host. Macrophages are triggered to release cytokines and chemokines, which cause increased vascular permeability and a procoagulant state.<xref ref-type="bibr" rid="article-116027.r9">[9]</xref>&#x000a0;These viruses can also trigger mechanisms resulting in disseminated intravascular coagulation. Infected dendritic cells are impaired, and the loss of its appropriate function can lead to lymphocytic apoptosis.<xref ref-type="bibr" rid="article-116027.r9">[9]</xref></p>
      </sec>
      <sec id="article-116027.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients can present with nonspecific symptoms, including fevers, headaches, and malaise. Clinical features that are considered common for VHFs include retro-orbital pain, joint pains, eye redness, abdominal pain, vomiting, and diarrhea. Patients may also complain of bleeding gums or epistaxis. In these cases, a physical examination may be notable for petechiae.</p>
      </sec>
      <sec id="article-116027.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The clinical evaluation for viral hemorrhagic fevers includes complete blood count with differential, comprehensive metabolic panel, type and cross, coagulation studies, liver function tests, as well as evaluation for bacterial infections with urinalysis, urine culture, chest x-ray, and blood cultures. Serological testing for virus-specific IgM and IgG can be helpful but is not as sensitive or specific as molecular-based testing. Reverse transcriptase-polymerase chain reaction and virus isolation via cell culture are methods that can be used for diagnostic testing.</p>
      </sec>
      <sec id="article-116027.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Appropriate management of individuals suspected to have viral hemorrhagic fever includes early diagnosis to both increase chances of survival and prevent nosocomial infections. Patients with symptoms or travel history suggestive of these diseases should be isolated, and all staff caring for persons under investigation should wear appropriate personal protective equipment (referred to as viral hemorrhagic fever isolation precautions). Research regarding treatment is ongoing; however, the cornerstone of current treatment is supportive care. See specific management guidelines below for those diseases which have the highest overall mortality rates.</p>
        <p>Lassa virus - Ribavirin has been shown to improve treatment outcomes when given early in the disease course; however, studies have been limited.<xref ref-type="bibr" rid="article-116027.r3">[3]</xref>&#x000a0;Newer agents such as favipiravir and LASV-specific monoclonal antibodies are currently being evaluated. There are currently no effective vaccines for Lassa fever.&#x000a0;</p>
        <p>Crimean-Congo hemorrhagic fever - Treatment largely remains supportive. Ribavarin has demonstrated an antiviral effect against this virus in vitro.<xref ref-type="bibr" rid="article-116027.r7">[7]</xref>&#x000a0;There is currently no effective vaccine for humans. Agricultural workers and those working with animals are encouraged to use insect repellant and avoid contact with blood and other bodily fluids from animals or humans that may be infected.&#x000a0;</p>
        <p>Ebola virus disease and Marburg hemorrhagic fever - Treatment involves supportive care. There are currently no vaccines available against the Marburg virus.<xref ref-type="bibr" rid="article-116027.r6">[6]</xref><xref ref-type="bibr" rid="article-116027.r7">[7]</xref>&#x000a0;There is currently one Food and Drug Administration approved Ebola vaccine against the Zaire ebolavirus<italic toggle="yes">.</italic><xref ref-type="bibr" rid="article-116027.r10">[10]</xref></p>
        <p>Dengue fever - There are currently no effective antiviral regimens available for treatment, thus management involves supportive care.<xref ref-type="bibr" rid="article-116027.r8">[8]</xref>&#x000a0;One vaccine is currently available in Latin America and Southeast Asia. However, the World Health Organization has&#x000a0;recommended that it only be given to individuals who have a previous history of dengue infection.<xref ref-type="bibr" rid="article-116027.r11">[11]</xref></p>
      </sec>
      <sec id="article-116027.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Acute&#x000a0;human immunodeficiency virus (HIV) infection</p>
          </list-item>
          <list-item>
            <p>Chikungunya virus</p>
          </list-item>
          <list-item>
            <p>Leptospirosis</p>
          </list-item>
          <list-item>
            <p>Malaria</p>
          </list-item>
          <list-item>
            <p>Malignancy</p>
          </list-item>
          <list-item>
            <p>Systemic lupus erythematosus&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Typhoid fever</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-116027.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>As viral hemorrhagic fevers encompass a wide variety of diseases, the prognosis varies. Many of these diseases are capable of causing outbreaks and are associated with high morbidity and mortality, as there are currently no specific therapies available. Case fatality rates can be as high as 80%-90% in developing countries.<xref ref-type="bibr" rid="article-116027.r6">[6]</xref></p>
      </sec>
      <sec id="article-116027.s11" sec-type="Complications">
        <title>Complications</title>
        <p>The most severe complications of viral hemorrhagic fevers involve multi-organ system failure and death. Management is largely supportive.&#x000a0;Given the risk for nosocomial infections and further outbreaks,&#x000a0;viral hemorrhagic fever isolation precautions should be instituted immediately if this entity is suspected.</p>
      </sec>
      <sec id="article-116027.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should be educated regarding the geographical distribution of these viruses and practice&#x000a0;infection prevention measures when traveling to areas where these diseases are endemic. The Centers for Disease Control, the World Health Organization, and the United States Department of State provide a list of resources regarding current areas with ongoing epidemics as well as travel notices and restrictions.</p>
      </sec>
      <sec id="article-116027.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>These infectious diseases are classified as category A bioweapons agents as they are stable when aerosolized and are associated with severe morbidity and mortality in infected individuals.<xref ref-type="bibr" rid="article-116027.r12">[12]</xref><xref ref-type="bibr" rid="article-116027.r13">[13]</xref></p>
      </sec>
      <sec id="article-116027.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Health care outcomes can be improved with an&#x000a0;interprofessional team approach whenever viral hemorrhagic fevers are suspected. Effective communication between clinicians, nurses, epidemiologists, virologists, and ecologists is necessary to help prevent any further spread of disease.<xref ref-type="bibr" rid="article-116027.r7">[7]</xref></p>
      </sec>
      <sec id="article-116027.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=116027&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=116027">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/viral-hemorrhagic-fevers/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=116027">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/116027/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=116027">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-116027.s16">
        <title>References</title>
        <ref id="article-116027.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Racsa</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Kraft</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Olinger</surname>
                <given-names>GG</given-names>
              </name>
              <name>
                <surname>Hensley</surname>
                <given-names>LE</given-names>
              </name>
            </person-group>
            <article-title>Viral Hemorrhagic Fever Diagnostics.</article-title>
            <source>Clin Infect Dis</source>
            <year>2016</year>
            <month>Jan</month>
            <day>15</day>
            <volume>62</volume>
            <issue>2</issue>
            <fpage>214</fpage>
            <page-range>214-9</page-range>
            <pub-id pub-id-type="pmid">26354968</pub-id>
          </element-citation>
        </ref>
        <ref id="article-116027.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Montoya-Ruiz</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rodas</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Epidemiological Surveillance of Viral Hemorrhagic Fevers With Emphasis on Clinical Virology.</article-title>
            <source>Methods Mol Biol</source>
            <year>2018</year>
            <volume>1604</volume>
            <fpage>55</fpage>
            <page-range>55-78</page-range>
            <pub-id pub-id-type="pmid">28986825</pub-id>
          </element-citation>
        </ref>
        <ref id="article-116027.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Asogun</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>G&#x000fc;nther</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Akpede</surname>
                <given-names>GO</given-names>
              </name>
              <name>
                <surname>Ihekweazu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zumla</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Lassa Fever: Epidemiology, Clinical Features, Diagnosis, Management and Prevention.</article-title>
            <source>Infect Dis Clin North Am</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>33</volume>
            <issue>4</issue>
            <fpage>933</fpage>
            <page-range>933-951</page-range>
            <pub-id pub-id-type="pmid">31668199</pub-id>
          </element-citation>
        </ref>
        <ref id="article-116027.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bente</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Forrester</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Watts</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>McAuley</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Whitehouse</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Bray</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity.</article-title>
            <source>Antiviral Res</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>100</volume>
            <issue>1</issue>
            <fpage>159</fpage>
            <page-range>159-89</page-range>
            <pub-id pub-id-type="pmid">23906741</pub-id>
          </element-citation>
        </ref>
        <ref id="article-116027.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hidalgo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Richards</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Jim&#x000e9;nez</surname>
                <given-names>JIS</given-names>
              </name>
              <name>
                <surname>Baker</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Amin</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Viral hemorrhagic fever in the tropics: Report from the task force on tropical diseases by the World Federation of Societies of Intensive and Critical Care Medicine.</article-title>
            <source>J Crit Care</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>42</volume>
            <fpage>366</fpage>
            <page-range>366-372</page-range>
            <pub-id pub-id-type="pmid">29128377</pub-id>
          </element-citation>
        </ref>
        <ref id="article-116027.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rougeron</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Feldmann</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Grard</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Becker</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Leroy</surname>
                <given-names>EM</given-names>
              </name>
            </person-group>
            <article-title>Ebola and Marburg haemorrhagic fever.</article-title>
            <source>J Clin Virol</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>64</volume>
            <fpage>111</fpage>
            <page-range>111-9</page-range>
            <pub-id pub-id-type="pmid">25660265</pub-id>
          </element-citation>
        </ref>
        <ref id="article-116027.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iannetta</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Di Caro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nicastri</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Vairo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Masanja</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kobinger</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mirazimi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ntoumi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Zumla</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ippolito</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Viral Hemorrhagic Fevers Other than Ebola and Lassa.</article-title>
            <source>Infect Dis Clin North Am</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>33</volume>
            <issue>4</issue>
            <fpage>977</fpage>
            <page-range>977-1002</page-range>
            <pub-id pub-id-type="pmid">31668201</pub-id>
          </element-citation>
        </ref>
        <ref id="article-116027.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kularatne</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Dengue fever.</article-title>
            <source>BMJ</source>
            <year>2015</year>
            <month>Sep</month>
            <day>15</day>
            <volume>351</volume>
            <fpage>h4661</fpage>
            <pub-id pub-id-type="pmid">26374064</pub-id>
          </element-citation>
        </ref>
        <ref id="article-116027.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bray</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Pathogenesis of viral hemorrhagic fever.</article-title>
            <source>Curr Opin Immunol</source>
            <year>2005</year>
            <month>Aug</month>
            <volume>17</volume>
            <issue>4</issue>
            <fpage>399</fpage>
            <page-range>399-403</page-range>
            <pub-id pub-id-type="pmid">15955687</pub-id>
          </element-citation>
        </ref>
        <ref id="article-116027.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ollmann Saphire</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>A Vaccine against Ebola Virus.</article-title>
            <source>Cell</source>
            <year>2020</year>
            <month>Apr</month>
            <day>02</day>
            <volume>181</volume>
            <issue>1</issue>
            <fpage>6</fpage>
            <pub-id pub-id-type="pmid">32243796</pub-id>
          </element-citation>
        </ref>
        <ref id="article-116027.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gubler</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Halstead</surname>
                <given-names>SB</given-names>
              </name>
            </person-group>
            <article-title>Is Dengvaxia a useful vaccine for dengue endemic areas?</article-title>
            <source>BMJ</source>
            <year>2019</year>
            <month>Oct</month>
            <day>03</day>
            <volume>367</volume>
            <fpage>l5710</fpage>
            <pub-id pub-id-type="pmid">31582375</pub-id>
          </element-citation>
        </ref>
        <ref id="article-116027.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Polesky</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bhatia</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Ebola hemorrhagic fever in the era of bioterrorism.</article-title>
            <source>Semin Respir Infect</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>18</volume>
            <issue>3</issue>
            <fpage>206</fpage>
            <page-range>206-15</page-range>
            <pub-id pub-id-type="pmid">14505282</pub-id>
          </element-citation>
        </ref>
        <ref id="article-116027.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Robenshtok</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Laster</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Katz</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Brenner</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sagi</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>[Viral hemorrhagic fever as a biological weapon].</article-title>
            <source>Harefuah</source>
            <year>2002</year>
            <month>May</month>
            <volume>141 Spec No</volume>
            <fpage>96</fpage>
            <page-range>96-9, 119</page-range>
            <pub-id pub-id-type="pmid">12170564</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
